
ADAMTS13
Kurzinformation



inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
This comprehensive volume discusses the protease ADAMTS13, summarizing the current status of basic and clinical research. The nine authoritative chapters begin with a historical perspective followed by exploration of the biochemistry and structure-function relationships of ADAMTS13 as well as its normal function in hemostasis (cleavage of von Willebrand factor). Emerging research themes for ADAMTS13 are covered, including its potential role in angiogenesis and other aspects of cell biology. Additional topics include laboratory assays for ADAMTS13, inherited ADAMTS13 deficiency, and acquired ADAMTS13 deficiency. A chapter on related thrombotic microangiopathic (TMA) disorders examines the differences between TMAs associated with ADAMTS13 deficiency and those not associated with ADAMTS13 deficiency. A final chapter reviews the preliminary information on emerging aspects of ADAMTS13, such as the status of recombinant ADAMTS13 products and their potential utility. Comprehensive in its exploration of the ADAMTS13 protease in disease, ADAMTS13: Biology and Disease is a significant resource for clinical hematologists, transfusion medicine physicians, and researchers interested in hemostasis, vascular biology, biochemistry, and metalloproteases. von Rodgers, George
Produktdetails

So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
Dr. George M. Rodgers received his M.D. and Ph.D. in Pharmacology from Tulane University Medical School in New Orleans, Louisiana. He completed his internal medicine training at Baylor College of Medicine in Houston, Texas, along with a hematology fellowship at the University of California, San Francisco, and served on the UCSF faculty. He is currently Professor of Medicine and Pathology at the University of Utah Medical Center in Salt Lake City and Medical Director of the Coagulation Laboratory at ARUP Laboratories. Dr. Rodgers is board certified in internal medicine, hematology and hematopathology. His clinical interests are in benign hematology, particularly coagulation disorders, and his basic research interests are in vascular biology, especially endothelial cell regulation of hemostasis. A current project is studying the role of ADAMTS13 in angiogenesis.
- Kartoniert
- 736 Seiten
- Erschienen 2007
- Springer
- hardcover
- 241 Seiten
- Erschienen 2014
- Springer
- Hardcover
- 136 Seiten
- Erschienen 2016
- Wiley-Blackwell
- paperback
- 500 Seiten
- Erschienen 2008
- Springer
- Kartoniert
- 358 Seiten
- Erschienen 2006
- Springer
- audioCD -
- Der HÖR Verlag DHV
- Hardcover
- 352 Seiten
- Erschienen 2000
- Oxford University Press
- Kartoniert
- 551 Seiten
- Erschienen 1996
- Springer
- paperback
- 98 Seiten
- Erschienen 2013
- TUDpress
- Hardcover
- 292 Seiten
- Erschienen 1996
- Teubner Verlag
- Hardcover
- 324 Seiten
- Erschienen 2002
- Springer
- Taschenbuch
- 920 Seiten
- Erschienen 1997
- John Wiley & Sons Inc
- Gebunden
- 46 Seiten
- Erschienen 2022
- Modo Press
- hardcover
- 553 Seiten
- Erschienen 2019
- Springer
- Hardcover -
- Erschienen 2012
- Hodder Education
- paperback
- 752 Seiten
- Erschienen 2024
- Faber & Faber
- perfect -
- Das Neue Berlin